Tag:
Requip
Latest Headlines
Latest Headlines
GSK slashes ReQuip price in U.K. by 60%
GlaxoSmithKline cut the U.K. price of Parkinson's treatment ReQuip XL by 60 percent, making it less expensive than competing dopamine agonists. Report
Tweaked Glaxo drugs mired in approval delays
GlaxoSmithKline is finding one of its key strategies blocked by a new foe: the FDA. The kind of drugs that are slightly tweaked versions of existing meds, rather than built-from-the-ground-up new
